SCHEMBL7329343

SCHEMBL7329343

CN(Cc1ccc2ccccc2n1)C(=O)N[C@@H](CC#N)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
PDK1 Q15118 1/20 0.38
USP9X Q93008 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
PRNP P04156 1/20 0.38
MAPK10 P53779 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
AGTR2 P50052 1/20 0.37
PDE10A Q9Y233 2/20 0.37
GAA P10253 1/20 0.36
CYSLTR1 Q9Y271 2/20 0.36
ADAMTS4 O75173 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
ALOX5 P09917 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27375082 0.86 HDAC1 (0.46) CYP1A2HDAC1HDAC2PDK1KDM4E
SCHEMBL7300357 0.86 HDAC1 (0.46) CYP1A2HDAC1HDAC2PDK1KDM4E
SCHEMBL7298672 0.85 CYP1A2 (0.43) CYP1A2HDAC1HDAC2PDK1USP9X
SCHEMBL7300431 0.83 MME (0.44) CYP1A2HDAC1HDAC2PDK1ALDH1A1
SCHEMBL7303578 0.82 CTSD (0.47) HDAC1HDAC2PDK1
SCHEMBL7388688 0.82 CYP1A2 (0.43) CYP1A2HDAC1HDAC2PDK1USP9X
SCHEMBL7337376 0.81 CYP1A2 (0.48) CYP1A2HDAC1HDAC2PDK1KDM4E
SCHEMBL7337373 0.81 CYP1A2 (0.48) CYP1A2HDAC1HDAC2PDK1KDM4E
SCHEMBL6946634 0.78 SIRT2 (0.45) CYP1A2HDAC1HDAC2CYSLTR1GPBAR1
SCHEMBL7305142 0.77 CYP1A2 (0.44) CYP1A2HDAC1HDAC2PDK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed